Cedars-Sinai receives $11.99 million from CIRM to launch ALS Clinical Trial

By | June 24, 2021
Cedars-Sinai has been awarded $11.99 million by California’s stem cell agency to launch a clinical trial testing a potential gene and stem cell therapy for amyotrophic lateral sclerosis (ALS).